Johanna Friedl-Naderer, EVP & Chief Operating Officer at Vir Biotechnology, Inc. (VIR), sold 1,482 shares at $22.82 ($34K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $34k VIR by EVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DYN | SELL | 2026-06-17 | $3K | — | Filing → |
| DYN | SELL | 2026-05-14 | $4K | — | Filing → |
| DYN | SELL | 2026-03-06 | $2K | — | Filing → |